Mao Y - Search Results

1

Hypoxia induced exosomal Circ-ZNF609 promotes pre-metastatic niche formation and cancer progression via miR-150-5p/VEGFA and HuR/ZO-1 axes in esophageal squamous cell carcinoma.

Mao Y, Wang J, Wang Y, Fu Z, Dong L, Liu J. Mao Y, et al. Cell Death Discov. 2024 Mar 12;10(1):133. doi: 10.1038/s41420-024-01905-8. Cell Death Discov. 2024. PMID: 38472174 Free PMC article.

2

A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma.

Mao Y, Fu Z, Zhang Y, Dong L, Zhang Y, Zhang Q, Li X, Liu J. Mao Y, et al. Sci Rep. 2018 Jun 11;8(1):8823. doi: 10.1038/s41598-018-27307-2. Sci Rep. 2018. PMID: 29891973 Free PMC article.

3

MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC).

Mao Y, Liu J, Zhang D, Li B. Mao Y, et al. Biomed Pharmacother. 2015 Dec;76:82-93. doi: 10.1016/j.biopha.2015.10.005. Epub 2015 Nov 10. Biomed Pharmacother. 2015. Retraction in: Biomed Pharmacother. 2024 Feb;171:116189. doi: 10.1016/j.biopha.2024.116189 PMID: 26653554 Retracted.

4

MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1.

Mao Y, Li L, Liu J, Wang L, Zhou Y. Mao Y, et al. Oncotarget. 2016 Aug 9;7(32):51223-51236. doi: 10.18632/oncotarget.9981. Oncotarget. 2016. PMID: 27323412 Free PMC article.

5

Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.

Zhang D, Zhang W, Liu W, Mao Y, Fu Z, Liu J, Huang W, Zhang Z, An D, Li B. Zhang D, et al. Among authors: mao y. Radiother Oncol. 2017 Jul;124(1):155-160. doi: 10.1016/j.radonc.2017.06.008. Epub 2017 Jun 21. Radiother Oncol. 2017. PMID: 28647401

6

miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.

Mao Y, Liu J, Zhang D, Li B. Mao Y, et al. Tumour Biol. 2016 Jul;37(7):9009-22. doi: 10.1007/s13277-015-4760-9. Epub 2016 Jan 13. Tumour Biol. 2016. PMID: 26758433

7

Erratum to: miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.

Mao Y, Liu J, Zhang D, Li B. Mao Y, et al. Tumour Biol. 2016 Nov;37(11):15343-15346. doi: 10.1007/s13277-016-5470-7. Tumour Biol. 2016. PMID: 27778234 No abstract available.

8

Retraction notice to "MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)" [Biomed. Pharmacother. 76 (2015) 82-93].

Mao Y, Liu J, Zhang D, Li B. Mao Y, et al. Biomed Pharmacother. 2024 Feb;171:116189. doi: 10.1016/j.biopha.2024.116189. Epub 2024 Jan 30. Biomed Pharmacother. 2024. PMID: 38296731 Free article. No abstract available.

9

Retraction notice to "MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma".

Liu J, Mao Y, Zhang D, Hao S, Zhang Z, Li Z, Li B. Liu J, et al. Among authors: mao y. Cancer Lett. 2018 May 28;422:133. doi: 10.1016/j.canlet.2018.03.021. Cancer Lett. 2018. PMID: 29579440 No abstract available.

10

RETRACTED: MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma.

Liu J, Mao Y, Zhang D, Hao S, Zhang Z, Li Z, Li B. Liu J, et al. Among authors: mao y. Cancer Lett. 2016 Apr 1;373(1):97-108. doi: 10.1016/j.canlet.2016.01.023. Epub 2016 Jan 21. Cancer Lett. 2016. Retraction in: Cancer Lett. 2018 May 28;422:133. doi: 10.1016/j.canlet.2018.03.021 PMID: 26806810 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,669 results

Search Page

Filters